top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights
Search

Galvanize Secures $100M Series C and Appoints Doug Godshall as CEO to Advance PEF Therapies

  • Sep 10, 2025
  • 1 min read

Redwood City, CA, September 3, 2025 (PRNewswire) -- Galvanize Therapeutics closed an oversubscribed $100 million Series C round led by Sofinnova Partners to develop its pulsed electric field (PEF) platform targeting solid tumors and chronic bronchitis. The funding will expand commercial operations and advance clinical programs for Aliya® PEF and RheOx® therapies. Doug Godshall was appointed CEO and Chairman, with Jonathan Waldstreicher becoming President and Chief Strategy Officer, marking a new leadership phase for the company.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments

Life Science Headlines
bottom of page